Last updated at 06 Jul 2024 12:05 AM
Director
DIN: 09250544
Jaya Krishna Vasireddy is currently associated with 2 companies in various capacities such as Director and Individual Promoter. They serve as a Director at QUALIGENCE HEALTH INDIA PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 09250544.Jaya Krishna Vasireddy is currently involved in 2 different roles. Their most recent position is with EXIGENCE PHARMA PRIVATE LIMITED as a Director. The first company Jaya Krishna Vasireddy was appointed to as a director was QUALIGENCE HEALTH INDIA PRIVATE LIMITED. Jaya Krishna Vasireddy is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Jaya Krishna Vasireddy is currently associated with 2 companies in various capacities such as Director and Individual Promoter. They serve as a Director at QUALIGENCE HEALTH INDIA PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 09250544.Jaya Krishna Vasireddy is currently involved in 2 different roles. Their most recent position is with EXIGENCE PHARMA PRIVATE LIMITED as a Director. The first company Jaya Krishna Vasireddy was appointed to as a director was QUALIGENCE HEALTH INDIA PRIVATE LIMITED. Jaya Krishna Vasireddy is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
3
Male
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (0)
Past Companies (0)
11 Months 6 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| QUALIGENCE HEALTH INDIA PRIVATE LIMITED | Director | 23-Jul-2021 |
| QUALIGENCE HEALTH INDIA PRIVATE LIMITED | Individual Promoter | 23-Jul-2021 |
| EXIGENCE PHARMA PRIVATE LIMITED | Director | 13-Mar-2024 |